Franconieri, F. (2016) “Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies”, Acta Oncologica, 55(7), pp. 930–932. doi: 10.3109/0284186X.2015.1120885.